These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 31053174)

  • 1. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
    Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
    J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
    Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
    Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
    Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
    APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis.
    Robbins Y; Friedman J; Clavijo PE; Sievers C; Bai K; Donahue RN; Schlom J; Sinkoe A; Hinrichs CS; Allen C; Abdul Sater H; Gulley JL; Norberg S
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent laryngeal papillomatosis with oesophageal involvement in a 2 year old boy: successful treatment with the quadrivalent human papillomatosis vaccine.
    Mészner Z; Jankovics I; Nagy A; Gerlinger I; Katona G
    Int J Pediatr Otorhinolaryngol; 2015 Feb; 79(2):262-6. PubMed ID: 25496821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus laryngeal tracheal papillomatosis.
    Alfano DM
    J Pediatr Health Care; 2014; 28(5):451-5. PubMed ID: 24882788
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
    Intakorn P; Sonsuwan N
    J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.
    Tjon Pian Gi RE; San Giorgi MR; Slagter-Menkema L; van Hemel BM; van der Laan BF; van den Heuvel ER; Dikkers FG; Schuuring EM
    Head Neck; 2015 Nov; 37(11):1625-32. PubMed ID: 24955561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Immunogenicity of a Nonadjuvant Human Papillomavirus Type 6 Virus-like Particle Vaccine in Recurrent Respiratory Papillomatosis.
    Zhang CQ; Yi S; Liu XJ; Nan BY; Huang SY; Chen BB
    J Voice; 2019 May; 33(3):363-369. PubMed ID: 30224308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
    Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
    J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
    Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
    Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In RRP, serologic response to HPV is frequently absent and slow to develop.
    Buchinsky FJ; Ruszkay N; Valentino W; Derkay CS; McClay JE; Bastian RW; Myer CM; Lollar KW; Guris D
    PLoS One; 2020; 15(3):e0230106. PubMed ID: 32160246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous Cell Papillomatosis in the Setting of Recurrent Respiratory Papillomatosis.
    Bentley PL; Coulter MJ; Nelson BL
    Head Neck Pathol; 2019 Jun; 13(2):235-238. PubMed ID: 29594918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and treatment course of lung carcinoma from adult-onset recurrent respiratory papillomatosis with lung involvement: A case report.
    Cardoso Figueiredo M; Chantre-Justino M; Latini Ruback R; Pires de Mello P; Alves G; Helena Ornellas M
    Oral Oncol; 2021 Oct; 121():105398. PubMed ID: 34167900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years.
    Kocjan BJ; Gale N; Hočevar Boltežar I; Seme K; Fujs Komloš K; Hošnjak L; Maver PJ; Jelen MM; Zupanič Pajnič I; Balažic J; Poljak M
    J Infect Dis; 2013 Feb; 207(4):583-7. PubMed ID: 23204170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
    Ilboudo M; Zohoncon TM; Traore IMA; Traore EMA; Kande A; Obiri-Yeboah D; Djigma FW; Gyebre YMC; Simpore J
    Am J Otolaryngol; 2019; 40(3):368-371. PubMed ID: 30799210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is recurrent respiratory papillomatosis a manageable or curable disease?
    Kim HT; Baizhumanova AS
    Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
    Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z
    J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant degeneration in laryngeal papillomatosis].
    Grøn AL; Schultz JH; Abildgaard J
    Ugeskr Laeger; 2011 Feb; 173(7):506-7. PubMed ID: 21320416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.